Second line treatment of metastatic renal cell carcinoma: The Institut Gustave Roussy experience with targeted therapies in 251 consecutive patients.
暂无分享,去创建一个
B. Escudier | Y. Loriot | K. Fizazi | A. Levy | L. Albiges | M. di Palma | J. Menard | M. Di Palma | A. Lévy